Michael Yao

3.3k total citations · 1 hit paper
30 papers, 2.3k citations indexed

About

Michael Yao is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Michael Yao has authored 30 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Michael Yao's work include Immunodeficiency and Autoimmune Disorders (5 papers), Immune Cell Function and Interaction (5 papers) and Inflammatory Bowel Disease (5 papers). Michael Yao is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (5 papers), Immune Cell Function and Interaction (5 papers) and Inflammatory Bowel Disease (5 papers). Michael Yao collaborates with scholars based in United States, Canada and Switzerland. Michael Yao's co-authors include Marc Vandemeulebroecke, Simon Travis, Peter Higgins, Walter Reinisch, Gerard Bruin, Steve Lewitzky, Arthur P. Bertolino, Marco Londei, Stephan Bek and Marek Karczewski and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Michael Yao

26 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

2012 1.2k citations Wolfgang Hueber, Bruce E. Sands et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Yao United States	16	1.3k	669	598	398	274	30	2.3k
Diane U. Leong United States	10	907 0.7×	468 0.7×	350 0.6×	516 1.3×	278 1.0×	12	2.2k
Björn R. Lúdvíksson Iceland	26	1.6k 1.3×	304 0.5×	484 0.8×	324 0.8×	233 0.9×	62	2.6k
Melanie A. Kleinschek United States	15	2.5k 2.0×	419 0.6×	632 1.1×	420 1.1×	141 0.5×	18	3.3k
Natalie J. Prescott United Kingdom	22	722 0.6×	675 1.0×	951 1.6×	329 0.8×	126 0.5×	45	1.9k
Panagiotis Skendros Greece	27	2.0k 1.6×	1.1k 1.6×	214 0.4×	477 1.2×	214 0.8×	70	3.2k
Hiroshi Chinen Japan	15	1.3k 1.0×	621 0.9×	768 1.3×	348 0.9×	78 0.3×	24	2.2k
Aarnoud Huissoon United Kingdom	27	1.0k 0.8×	298 0.4×	257 0.4×	249 0.6×	380 1.4×	68	2.7k
Jørgen Agnholt Denmark	28	676 0.5×	448 0.7×	877 1.5×	807 2.0×	242 0.9×	77	2.5k
Mina T. Kitazume Japan	17	1.4k 1.1×	625 0.9×	842 1.4×	432 1.1×	84 0.3×	20	2.4k
B. H. Belohradsky Germany	25	958 0.8×	509 0.8×	318 0.5×	487 1.2×	407 1.5×	99	2.4k

Countries citing papers authored by Michael Yao

Since Specialization

Citations

This map shows the geographic impact of Michael Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Yao more than expected).

Fields of papers citing papers by Michael Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Yao. The network helps show where Michael Yao may publish in the future.

Co-authorship network of co-authors of Michael Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Yao. A scholar is included among the top collaborators of Michael Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Yao. Michael Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lu, Tianqi Li, Peike Sheng, et al.. (2025). An endogenous cluster of target-directed microRNA degradation sites induces decay of distinct microRNA families. Cell Reports. 44(9). 116162–116162. 2 indexed citations

Yao, Michael, Jason Daniels, Luke P. Grosvenor, et al.. (2024). Commonly used genomic arrays may lose information due to imperfect coverage of discovered variants for autism spectrum disorder. Journal of Neurodevelopmental Disorders. 16(1). 54–54.

Gutmark‐Little, Iris, et al.. (2023). Abnormal Uterine Bleeding during Pubertal Induction with Transdermal Estrogen in Individuals with Turner Syndrome. Journal of Pediatric and Adolescent Gynecology. 36(4). 358–362. 3 indexed citations

Wang, Zhanhuai, Xiaochun Yang, Wilma Jogunoori, et al.. (2021). Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(10). 166179–166179. 16 indexed citations

Gu, Shoujun, Sobia Zaidi, Md. Imtaiyaz Hassan, et al.. (2019). Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology. 158(1). 238–252. 50 indexed citations

Shulzhenko, Natalia, Xiaoxi Dong, Renee L. Greer, et al.. (2018). CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont. Clinical Immunology. 197. 139–153. 51 indexed citations

Mao, Liming, Atsushi Kitani, Morgan Similuk, et al.. (2018). Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease. Journal of Clinical Investigation. 128(5). 1793–1806. 75 indexed citations

Jennings, Joseph, Charles Faselis, & Michael Yao. (2017). NAFLD-NASH: An Under-Recognized Epidemic. Current Vascular Pharmacology. 16(3). 209–213. 31 indexed citations

Greer, Renee L., Xiaoxi Dong, Ana Carolina Franco de Moraes, et al.. (2016). Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nature Communications. 7(1). 13329–13329. 220 indexed citations

10.

Kovacs, Stephen B., Virginia Sheikh, William L. Thompson, et al.. (2015). T-Cell Depletion in the Colonic Mucosa of Patients With Idiopathic CD4⁺Lymphopenia. The Journal of Infectious Diseases. 212(10). 1579–1587. 9 indexed citations

11.

Kamal, Natasha, Nancy T. Ho, Martha Quezado, et al.. (2015). Gastrointestinal Features of Chronic Granulomatous Disease Found During Endoscopy. Clinical Gastroenterology and Hepatology. 14(3). 395–402.e5. 40 indexed citations

12.

Fuss, Ivan J., Bharat Joshi, Zhiqiong Yang, et al.. (2014). IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis. Gut. 63(11). 1728–1736. 65 indexed citations

13.

Sereti, Irini, Jacob D. Estes, William L. Thompson, et al.. (2014). Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration. PLoS Pathogens. 10(1). e1003890–e1003890. 76 indexed citations

14.

Buckner, Clarisa M., Susan Moir, Lela Kardava, et al.. (2013). CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation. Journal of Allergy and Clinical Immunology. 133(6). 1676–1685.e5. 21 indexed citations

15.

Hueber, Wolfgang, Bruce E. Sands, Steve Lewitzky, et al.. (2012). Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 61(12). 1693–1700. 1156 indexed citations breakdown →

16.

Dagur, Pradeep K., Angélique Biancotto, Lai Wei, et al.. (2011). MCAM-expressing CD4+ T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. Journal of Autoimmunity. 37(4). 319–327. 55 indexed citations

17.

Read, Sarah W., Emily J. Ciccone, Peter Mannon, et al.. (2011). The Effect of Intermittent IL-2 Therapy on CD4 T Cells in the Gut in HIV-1–Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(4). 340–343. 6 indexed citations

18.

Hou, Hsin‐An, Wen‐Chien Chou, Mei‐Hui Tseng, et al.. (2011). 300 Clinical features and prognostic factors of myelodysplastic syndrome in Taiwan. Leukemia Research. 35. S118–S118. 1 indexed citations

19.

Shulzhenko, Natalia, Andrey Morgun, William Hsiao, et al.. (2011). Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nature Medicine. 17(12). 1585–1593. 267 indexed citations

20.

Yao, Michael, Erik C. von Rosenvinge, Catherine Groden, & Peter Mannon. (2009). Multiple endoscopic biopsies in research subjects: safety results from a National Institutes of Health series. Gastrointestinal Endoscopy. 69(4). 906–910. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact